Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on aTyr Pharma (ATYR) and Idexx Laboratories (IDXX).
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
aTyr Pharma (ATYR)
In a report released today, Soumit Roy from JonesTrading maintained a Hold rating on aTyr Pharma. The company’s shares closed last Monday at $0.82.
According to TipRanks.com, Roy is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for aTyr Pharma with a $7.33 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Idexx Laboratories (IDXX)
William Blair analyst Ryan Daniels maintained a Buy rating on Idexx Laboratories today. The company’s shares closed last Monday at $577.44.
According to TipRanks.com, Daniels is a 1-star analyst with an average return of
Idexx Laboratories has an analyst consensus of Moderate Buy, with a price target consensus of $764.29, implying a 35.0% upside from current levels. In a report issued on March 26, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $651.00 price target.
Read More on ATYR:
